Cancellation of state registration. Vagotil

March 28, 2017
Active substances:
Trade names:
ICD-10:
I.A50-A64.A59    Trichomoniasis
I.B35-B49.B37.3    Candidiasis of the vulva and vagina (N77.1 *)
IX.I80-I89.I83.2    Varicose veins of the lower extremities with ulcer and inflammation
XIV.N80-N98.N86    Erosion and ectropion of the cervix
XIX.T80-T88.T81.0    Bleeding and hematoma complicating the procedure, not elsewhere classified
Vagotil, polycreatic, vaginitis, cervical erosion, bleeding after cervical biopsy, trophic ulcers

The Ministry of Health of the Russian Federation in accordance with Article 32Federal Law No. 61-FZ dated 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N015042 / 01 dated July 31, 2008 issued Pabianicki pharmaceutical factory Polfa JSC, Poland):

Vagotil (trade name of the medicinal product)

Polycrezulen (international non-proprietary, or grouping, or chemical name medicinal product)

solution for topical application, 36% (dosage form, dosage)

Pabianice Pharmaceutical Plant Polfa JSC, Poland 5 Marszalka J.Pilsudskiego Str., 95-200 Pabianice, Poland (name and address of the location of the manufacturer of the medicinal product)

on the basis of a filing by an authorized legal entity LLC Adamed Rasha, Russia of a request for the cancellation of the state registration of a medicinal product.